Cargando…
Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
Autores principales: | Chhablani, Jay Kumar, Narula, Ritesh, Narayanan, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665049/ https://www.ncbi.nlm.nih.gov/pubmed/23514656 http://dx.doi.org/10.4103/0301-4738.109390 |
Ejemplares similares
-
Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014) -
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013) -
Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
por: Singh, Sumit Randhir, et al.
Publicado: (2019) -
Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2010) -
Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2011)